SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'HMD'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OPJ_B_STIB4_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	4 / 6	LEU X 34 ILE X 115 MET X 120 ARG X 171	HMD X 400 ( 4.3A) None None None	1.05A	1opjB-2pmoX: 20.4	1opjB-2pmoX: 24.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OPJ_B_STIB4_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	4 / 6	LEU X 34 LYS X 55 ILE X 115 ARG X 171	HMD X 400 ( 4.3A) HMD X 400 (-4.2A) None None	0.94A	1opjB-2pmoX: 20.4	1opjB-2pmoX: 24.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YFX_A_VGHA9000_1 (TYROSINE-PROTEIN KINASE RECEPTOR)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	5 / 8	LEU X 34 ALA X 53 MET X 120 LEU X 179 ASP X 190	HMD X 400 ( 4.3A) HMD X 400 (-3.5A) None HMD X 400 (-4.7A) HMD X 400 (-3.7A)	0.55A	2yfxA-2pmoX: 21.7	2yfxA-2pmoX: 24.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AOX_A_EMHA901_1 (ALK TYROSINE KINASE RECEPTOR)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	6 / 10	ARG X 32 LEU X 34 ALA X 53 LYS X 55 MET X 120 LEU X 179	None HMD X 400 ( 4.3A) HMD X 400 (-3.5A) HMD X 400 (-4.2A) None HMD X 400 (-4.7A)	0.86A	3aoxA-2pmoX: 21.4	3aoxA-2pmoX: 24.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZBF_A_VGHA3000_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	5 / 12	ALA X 53 LEU X 101 MET X 120 LEU X 179 ASP X 190	HMD X 400 (-3.5A) HMD X 400 (-4.2A) None HMD X 400 (-4.7A) HMD X 400 (-3.7A)	0.38A	3zbfA-2pmoX: 18.5	3zbfA-2pmoX: 22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	3 / 3	TYR X 119 MET X 120 ILE X 178	HMD X 400 (-4.5A) None None	0.92A	4c8bB-2pmoX: 3.2	4c8bB-2pmoX: 25.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CKJ_A_ADNA2014_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	6 / 10	LEU X 34 GLY X 37 ALA X 53 TYR X 119 SER X 124 LEU X 179	HMD X 400 ( 4.3A) None HMD X 400 (-3.5A) HMD X 400 (-4.5A) None HMD X 400 (-4.7A)	0.60A	4ckjA-2pmoX: 25.2	4ckjA-2pmoX: 24.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_B_8PRB601_1 (RHODOPSIN KINASE)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	5 / 8	GLY X 37 ALA X 53 LYS X 55 MET X 120 LEU X 179	None HMD X 400 (-3.5A) HMD X 400 (-4.2A) None HMD X 400 (-4.7A)	0.72A	4l9iB-2pmoX: 26.3	4l9iB-2pmoX: 24.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OTW_A_DB8A1101_2 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	3 / 3	LEU X 101 LEU X 89 ASN X 40	HMD X 400 (-4.2A) None None	0.44A	4otwA-2pmoX: 1.7	4otwA-2pmoX: 19.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMS_A_1N1A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	6 / 11	ALA X 53 LYS X 55 ILE X 115 TYR X 119 LEU X 179 ASP X 190	HMD X 400 (-3.5A) HMD X 400 (-4.2A) None HMD X 400 (-4.5A) HMD X 400 (-4.7A) HMD X 400 (-3.7A)	0.76A	4qmsA-2pmoX: 30.0	4qmsA-2pmoX: 29.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QRC_A_0LIA802_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	4 / 8	LEU X 34 LYS X 55 HIS X 170 LEU X 179	HMD X 400 ( 4.3A) HMD X 400 (-4.2A) None HMD X 400 (-4.7A)	0.80A	4qrcA-2pmoX: 21.6	4qrcA-2pmoX: 21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZV_A_032A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	6 / 12	ALA X 53 LYS X 55 LEU X 101 ILE X 115 SER X 124 PHE X 191	HMD X 400 (-3.5A) HMD X 400 (-4.2A) HMD X 400 (-4.2A) None None None	0.95A	4rzvA-2pmoX: 22.5	4rzvA-2pmoX: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U5J_A_RXTA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	8 / 11	LEU X 34 GLY X 37 ALA X 53 TYR X 119 MET X 120 ASN X 177 LEU X 179 ASP X 190	HMD X 400 ( 4.3A) None HMD X 400 (-3.5A) HMD X 400 (-4.5A) None HMD X 400 (-4.6A) HMD X 400 (-4.7A) HMD X 400 (-3.7A)	0.49A	4u5jA-2pmoX: 23.8	4u5jA-2pmoX: 23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U5J_B_RXTB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	6 / 9	LEU X 34 ALA X 53 TYR X 119 MET X 120 LEU X 179 ASP X 190	HMD X 400 ( 4.3A) HMD X 400 (-3.5A) HMD X 400 (-4.5A) None HMD X 400 (-4.7A) HMD X 400 (-3.7A)	0.78A	4u5jB-2pmoX: 23.0	4u5jB-2pmoX: 23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UXQ_A_0LIA1752_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	5 / 12	LEU X 34 ALA X 53 ILE X 95 HIS X 170 LEU X 179	HMD X 400 ( 4.3A) HMD X 400 (-3.5A) None None HMD X 400 (-4.7A)	0.53A	4uxqA-2pmoX: 21.4	4uxqA-2pmoX: 22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WBO_B_ANWB601_0 (RHODOPSIN KINASE)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	4 / 8	LEU X 34 ALA X 53 LEU X 179 SER X 189	HMD X 400 ( 4.3A) HMD X 400 (-3.5A) HMD X 400 (-4.7A) HMD X 400 ( 3.9A)	0.32A	4wboB-2pmoX: 26.2	4wboB-2pmoX: 21.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WBO_C_ANWC601_0 (RHODOPSIN KINASE)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	5 / 6	ARG X 32 LEU X 34 ALA X 53 MET X 120 LEU X 179	None HMD X 400 ( 4.3A) HMD X 400 (-3.5A) None HMD X 400 (-4.7A)	0.79A	4wboC-2pmoX: 26.9	4wboC-2pmoX: 21.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	5 / 12	ALA X 53 LYS X 55 LEU X 101 ASP X 190 PHE X 191	HMD X 400 (-3.5A) HMD X 400 (-4.2A) HMD X 400 (-4.2A) HMD X 400 (-3.7A) None	0.72A	4xv2A-2pmoX: 22.0	4xv2A-2pmoX: 24.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	5 / 12	ALA X 53 LYS X 55 LEU X 101 ASP X 190 PHE X 191	HMD X 400 (-3.5A) HMD X 400 (-4.2A) HMD X 400 (-4.2A) HMD X 400 (-3.7A) None	0.65A	4xv2B-2pmoX: 22.4	4xv2B-2pmoX: 24.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H2U_C_1N1C501_1 (PROTEIN-TYROSINE KINASE 6)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	5 / 12	ARG X 32 LEU X 34 ALA X 53 ILE X 115 LEU X 179	None HMD X 400 ( 4.3A) HMD X 400 (-3.5A) None HMD X 400 (-4.7A)	0.55A	5h2uC-2pmoX: 5.2	5h2uC-2pmoX: 24.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5P9I_A_1E8A701_2 (TYROSINE-PROTEIN KINASE BTK)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	4 / 5	LEU X 34 TYR X 119 MET X 120 ASP X 190	HMD X 400 ( 4.3A) HMD X 400 (-4.5A) None HMD X 400 (-3.7A)	0.96A	5p9iA-2pmoX: 21.4	5p9iA-2pmoX: 26.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	2pmo	SER/THR PROTEIN KINASE (Plasmodium falciparum)	3 / 3	TYR X 119 LEU X 179 ASP X 190	HMD X 400 (-4.5A) HMD X 400 (-4.7A) HMD X 400 (-3.7A)	0.67A	5zv2B-2pmoX: 20.7	5zv2B-2pmoX: 12.43

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1OPJ_B_STIB4_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",4,"LEU X  34;ILE X 115;MET X 120;ARG X 171","HMD X 400 ( 4.3A);None;None;None","1.05A","1opjB-2pmoX:20.4",null],["1OPJ_B_STIB4_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",4,"LEU X  34;LYS X  55;ILE X 115;ARG X 171","HMD X 400 ( 4.3A);HMD X 400 (-4.2A);None;None","0.94A","1opjB-2pmoX:20.4","1opjB-2pmoX:24.86"],["2YFX_A_VGHA9000_1","TYROSINE-PROTEIN KINASE RECEPTOR","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",5,"LEU X  34;ALA X  53;MET X 120;LEU X 179;ASP X 190","HMD X 400 ( 4.3A);HMD X 400 (-3.5A);None;HMD X 400 (-4.7A);HMD X 400 (-3.7A)","0.55A","2yfxA-2pmoX:21.7","1opjB-2pmoX:24.86"],["3AOX_A_EMHA901_1","ALK TYROSINE KINASE RECEPTOR","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",6,"ARG X  32;LEU X  34;ALA X  53;LYS X  55;MET X 120;LEU X 179","None;HMD X 400 ( 4.3A);HMD X 400 (-3.5A);HMD X 400 (-4.2A);None;HMD X 400 (-4.7A)","0.86A","3aoxA-2pmoX:21.4","2yfxA-2pmoX:24.01"],["3ZBF_A_VGHA3000_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",5,"ALA X  53;LEU X 101;MET X 120;LEU X 179;ASP X 190","HMD X 400 (-3.5A);HMD X 400 (-4.2A);None;HMD X 400 (-4.7A);HMD X 400 (-3.7A)","0.38A","3zbfA-2pmoX:18.5","3aoxA-2pmoX:24.23"],["4C8B_B_0LIB1000_2","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",3,"TYR X 119;MET X 120;ILE X 178","HMD X 400 (-4.5A);None;None","0.92A","4c8bB-2pmoX:3.2","3zbfA-2pmoX:22.98"],["4CKJ_A_ADNA2014_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",6,"LEU X  34;GLY X  37;ALA X  53;TYR X 119;SER X 124;LEU X 179","HMD X 400 ( 4.3A);None;HMD X 400 (-3.5A);HMD X 400 (-4.5A);None;HMD X 400 (-4.7A)","0.60A","4ckjA-2pmoX:25.2","4c8bB-2pmoX:25.53"],["4L9I_B_8PRB601_1","RHODOPSIN KINASE","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",5,"GLY X  37;ALA X  53;LYS X  55;MET X 120;LEU X 179","None;HMD X 400 (-3.5A);HMD X 400 (-4.2A);None;HMD X 400 (-4.7A)","0.72A","4l9iB-2pmoX:26.3","4ckjA-2pmoX:24.26"],["4OTW_A_DB8A1101_2","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",3,"LEU X 101;LEU X  89;ASN X  40","HMD X 400 (-4.2A);None;None","0.44A","4otwA-2pmoX:1.7","4l9iB-2pmoX:24.16"],["4QMS_A_1N1A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",6,"ALA X  53;LYS X  55;ILE X 115;TYR X 119;LEU X 179;ASP X 190","HMD X 400 (-3.5A);HMD X 400 (-4.2A);None;HMD X 400 (-4.5A);HMD X 400 (-4.7A);HMD X 400 (-3.7A)","0.76A","4qmsA-2pmoX:30.0","4otwA-2pmoX:19.52"],["4QRC_A_0LIA802_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",4,"LEU X  34;LYS X  55;HIS X 170;LEU X 179","HMD X 400 ( 4.3A);HMD X 400 (-4.2A);None;HMD X 400 (-4.7A)","0.80A","4qrcA-2pmoX:21.6","4qmsA-2pmoX:29.36"],["4RZV_A_032A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",6,"ALA X  53;LYS X  55;LEU X 101;ILE X 115;SER X 124;PHE X 191","HMD X 400 (-3.5A);HMD X 400 (-4.2A);HMD X 400 (-4.2A);None;None;None","0.95A","4rzvA-2pmoX:22.5","4qrcA-2pmoX:21.91"],["4U5J_A_RXTA601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",8,"LEU X  34;GLY X  37;ALA X  53;TYR X 119;MET X 120;ASN X 177;LEU X 179;ASP X 190","HMD X 400 ( 4.3A);None;HMD X 400 (-3.5A);HMD X 400 (-4.5A);None;HMD X 400 (-4.6A);HMD X 400 (-4.7A);HMD X 400 (-3.7A)","0.49A","4u5jA-2pmoX:23.8","4rzvA-2pmoX:25.00"],["4U5J_B_RXTB601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",6,"LEU X  34;ALA X  53;TYR X 119;MET X 120;LEU X 179;ASP X 190","HMD X 400 ( 4.3A);HMD X 400 (-3.5A);HMD X 400 (-4.5A);None;HMD X 400 (-4.7A);HMD X 400 (-3.7A)","0.78A","4u5jB-2pmoX:23.0","4u5jA-2pmoX:23.20"],["4UXQ_A_0LIA1752_1","FIBROBLAST GROWTH FACTOR RECEPTOR 4","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",5,"LEU X  34;ALA X  53;ILE X  95;HIS X 170;LEU X 179","HMD X 400 ( 4.3A);HMD X 400 (-3.5A);None;None;HMD X 400 (-4.7A)","0.53A","4uxqA-2pmoX:21.4","4u5jB-2pmoX:23.20"],["4WBO_B_ANWB601_0","RHODOPSIN KINASE","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",4,"LEU X  34;ALA X  53;LEU X 179;SER X 189","HMD X 400 ( 4.3A);HMD X 400 (-3.5A);HMD X 400 (-4.7A);HMD X 400 ( 3.9A)","0.32A","4wboB-2pmoX:26.2","4uxqA-2pmoX:22.13"],["4WBO_C_ANWC601_0","RHODOPSIN KINASE","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",5,"ARG X  32;LEU X  34;ALA X  53;MET X 120;LEU X 179","None;HMD X 400 ( 4.3A);HMD X 400 (-3.5A);None;HMD X 400 (-4.7A)","0.79A","4wboC-2pmoX:26.9","4wboB-2pmoX:21.42"],["4XV2_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",5,"ALA X  53;LYS X  55;LEU X 101;ASP X 190;PHE X 191","HMD X 400 (-3.5A);HMD X 400 (-4.2A);HMD X 400 (-4.2A);HMD X 400 (-3.7A);None","0.72A","4xv2A-2pmoX:22.0","4wboC-2pmoX:21.42"],["4XV2_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",5,"ALA X  53;LYS X  55;LEU X 101;ASP X 190;PHE X 191","HMD X 400 (-3.5A);HMD X 400 (-4.2A);HMD X 400 (-4.2A);HMD X 400 (-3.7A);None","0.65A","4xv2B-2pmoX:22.4","4xv2A-2pmoX:24.86"],["5H2U_C_1N1C501_1","PROTEIN-TYROSINE KINASE 6","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",5,"ARG X  32;LEU X  34;ALA X  53;ILE X 115;LEU X 179","None;HMD X 400 ( 4.3A);HMD X 400 (-3.5A);None;HMD X 400 (-4.7A)","0.55A","5h2uC-2pmoX:5.2","4xv2B-2pmoX:24.86"],["5P9I_A_1E8A701_2","TYROSINE-PROTEIN KINASE BTK","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",4,"LEU X  34;TYR X 119;MET X 120;ASP X 190","HMD X 400 ( 4.3A);HMD X 400 (-4.5A);None;HMD X 400 (-3.7A)","0.96A","5p9iA-2pmoX:21.4","5h2uC-2pmoX:24.37"],["5ZV2_B_LEVB801_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1","2pmo","SER\/THR PROTEIN KINASE","Plasmodium falciparum",3,"TYR X 119;LEU X 179;ASP X 190","HMD X 400 (-4.5A);HMD X 400 (-4.7A);HMD X 400 (-3.7A)","0.67A","5zv2B-2pmoX:20.7","5p9iA-2pmoX:26.22"]]